• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Edurant (rilpivirine) tablet

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2013

Summary View



  • In addition to the drugs included in Table 4, the interaction between Edurant and the following drugs was evaluated in clinical studies and no dose adjustment is needed for either drug digoxin,... raltegravir, ...telaprevir